Abstract:Background: Circulating microRNAs (miRNAs) have proved to be promising biomarkers for early diagnosis and therapeutic monitoring in cancers. Particularly for hepatocellular carcinoma (HCC), detection of circulating miRNA biomarkers as a new diagnostic approach has been written into the latest Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 edition). However, no general consensus on an ideal endogenous normalizer for circulating miRNAs quantification has been reached, so it will affect the accuracy of quantitative results. In this study, we aim to identify a stable endogenous normalizer for analyzing circulating miRNAs. Methods: Candidate miRNAs were selected by screening dataset GSE104310, as well as data statistics and analysis. Five commonly reference genes were chosen for further comparison and verification. Then, the expression levels of these genes in serum were analyzed by quantitative reverse transcription PCR (RT-qPCR) among four groups, including patients diagnosed with HCC, chronic hepatitis B (CHB), liver cirrhosis, and healthy subjects. Furthermore, the stability of target genes was evaluated using geNorm, NormFinder, comparative Delta Cq programs, and validated by database. We also explored the availability of the miRNA combination, and compared the performance difference between combination and individuals, as well as the selectivity of miRNA references in the combinations. Results: 11 candidate miRNAs were obtained, and miR-4644 stood out among these miRNAs, and proved to be much more stable than other endogenous miRNAs. Further study showed that miR-4644 exhibited higher stability and expression abundance than other commonly miRNA reference controls. Finally, we discovered the combination of miR-4644 and miR-16 revealed high performance in stability when compared to miRNA individuals. Furthermore, the combination consisted of references with closer nature could give rise to amplification effects in stability. Conclusions: Our findings demonstrated that miR-4644 is an ideal endogenous normalizer for circulating microRNA quantification in hepatocellular carcinoma. Besides, combining miR-4644 with miR-16 into a whole as a reference control would greatly improve the accuracy of quantification.

Stability analysis of liver cancer-related microRNAs

Factors Influencing Circulating MicroRNA Level in the Studies of Hepatocellular Carcinoma Biomarker.

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.

Serum/Plasma MicroRNAs As Biomarkers for HBV-Related Hepatocellular Carcinoma in China

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

Human Mir-1228 As a Stable Endogenous Control for the Quantification of Circulating Micrornas in Cancer Patients.

The expression of miRNA let-7a and miRNA let-7f in primary liver cancer patients

Analytical platform to validate microRNA biomarkers for cancer or disease with practically 100% sensitivity and specificity

Progress of Serum microRNA Detection and Clinical Application

Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma

Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges

Mrna and Microrna Stability Validation of Blood Samples under Different Environmental Conditions

Identification And Validation Of Reference Genes For Qpcr Detection Of Serum Micrornas In Colorectal Adenocarcinoma Patients

Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy

Identification and validation of key miRNAs and a microRNA-mRNA regulatory network associated with liver cancer

A Meta-Analysis Of Microrna Expression In Liver Cancer

Identification and validation of suitable reference genes for the investigation of serum microRNA in bladder cancer patients

Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases

Serum Mirnas As Predictive and Preventive Biomarker for Pre-Clinical Hepatocellular Carcinoma